FDA Inspection 920747 — Caplin, Dr David
The FDA completed an inspection of Caplin, Dr David on Mar 26, 2015 in Creve Coeur, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 26, 2015
- Fiscal Year
- 2015
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Creve Coeur, MO (United States)
Additional Details
Clinical Investigator (CI)